What sectors does Sofinnova Partners invest in?

Europe's leading life sciences VC, founded in 1972. Hands-on company builder across biopharma, medtech, industrial biotech, and sustainability. Over 500 companies backed.

Typical check size

€2M – €30M

Fund size: €4B+ AUM; Capital XI: €650M

Browse similar check sizes →

Portfolio highlights

Amolyt Pharma - rare endocrine diseases (acquired by AstraZeneca, 2024)

CinCor Pharma - cardiovascular (acquired by AstraZeneca, 2023)

Hemab Therapeutics - blood coagulation disorders

Contact

sofinnovapartners.com

France

Research with AI

Learn more about Sofinnova Partners using AI:

Ask ChatGPT Ask Perplexity

Pitch guides

Learn what Sofinnova Partners and similar investors look for:

Biotech pitch guide Cleantech pitch guide Healthtech pitch guide

More investors in France

360 Capital Alven Andera Partners BlackFin Capital Partners View all in France

Related resources

Seed fundraising guide Seed pitch deck guide Series A fundraising guide Series A pitch deck guide Series B fundraising guide Growth fundraising guide

Fundraising in France

Tips, programs, and cultural notes

More Biotech investors

Abingworth ACF Investors Ahren Innovation Capital Almi Invest GreenTech View all Biotech investors

Venture capital

France

Sofinnova Partners

Investment focus

Sectors

Biotech

Cleantech

Healthtech

Investment stages

Geographic focus

Europe

France

Investment thesis

Europe's leading life sciences VC, founded in 1972. Hands-on company builder across biopharma, medtech, industrial biotech, and sustainability. Over 500 companies backed.